FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361010483> ?p ?o ?g. }

• W4361010483 endingPage "354" @default.
• W4361010483 startingPage "343" @default.
• W4361010483 abstract "Globally, the rate of opioid prescription is high for chronic musculoskeletal conditions despite guidelines recommending against their use as their adverse effects outweigh their modest benefit. Deprescribing opioids is a complex process that can be hindered by multiple prescriber- and patient-related barriers. These include fear of the process of, or outcomes from, weaning medications, or a lack of ongoing support. Thus, involving patients, their carers, and healthcare professionals (HCPs) in the development of consumer materials that can educate and provide support for patients and HCPs over the deprescribing process is critical to ensure that the resources have high readability, usability, and acceptability to the population of interest.This study aimed to (1) develop two educational consumer leaflets to support opioid tapering in older people with low back pain (LBP) and hip or knee osteoarthritis (HoKOA), and (2) evaluate the perceived usability, acceptability, and credibility of the consumer leaflets from the perspective of consumers and HCPs.This was an observational survey involving a consumer review panel and an HCP review panel.30 consumers (and/or their carers) and 20 HCPs were included in the study. Consumers were people older than 65 years of age who were currently experiencing LBP or HoKOA, and with no HCP background. Carers were people who provided unpaid care, support, or assistance to an individual meeting the inclusion criteria for consumers. HCPs included physiotherapists (n = 9), pharmacists (n = 7), an orthopaedic surgeon (n = 1), a rheumatologist (n = 1), nurse practitioner (n = 1) and a general practitioner (n = 1), all with at least three years of clinical experience and who reported working closely with this target patient population within the last 12 months.Prototypes of two educational consumer leaflets (a brochure and a personal plan) were developed by a team of LBP, OA, and geriatric pharmacotherapy researchers and clinicians. The leaflet prototypes were evaluated by two separate chronological review panels involving (1) consumers and/or their carers, and (2) HCPs. Data collection for both panels occurred via an online survey. Outcomes were the perceived usability, acceptability, and credibility of the consumer leaflets. Feedback received from the consumer panel was used to refine the leaflets, before circulating the leaflets for further review by the HCP panel. Additional feedback from the HCP review panel was then used to refine the final versions of the consumer leaflets.Both consumers and HCPs perceived the leaflets and personal plan to be usable, acceptable, and credible. Consumers rated the brochure against several categories, which scored between 53 and 97% positive responses. Similarly, the overall feedback provided by HCPs was 85-100% positive. The modified System Usability Scale scores obtained from HCPs was 55-95% positive, indicating excellent usability. Feedback for the personal plan from both HCPs and consumers was largely positive, with consumers providing the highest positive ratings (80-93%). While feedback for HCPs was also high, we did identify that prescribers were hesitant to provide the plan to patients frequently (no positive responses).This study led to the development of a leaflet and personal plan to support the reduction of opioid use in older people with LBP or HoKOA. The development of the consumer leaflets incorporated feedback provided by HCPs and consumers to maximise clinical effectiveness and future intervention implementation.Opioids are medications that are often used to treat severe or chronic pain. However, they can have serious adverse effects and are not usually recommended for long-term use. This study aimed to create educational materials for patients with chronic low back pain or hip or knee osteoarthritis who are taking opioids and to evaluate the materials’ perceived usability, acceptability, and credibility from the perspective of both healthcare professionals (HCPs) and patients. The materials included a brochure and a personal plan and were developed by a team of researchers and clinicians. Both materials were evaluated by HCPs and patients in separate review panels. The brochure and personal plan were found to be usable, acceptable, and credible by both groups. The materials were created to support patients in reducing their opioid use and were refined based on feedback from both HCPs and patients. The materials may be useful in supporting the complex process of tapering off opioids, which can be hindered by various barriers related to both patients and HCPs." @default.
• W4361010483 created "2023-03-30" @default.
• W4361010483 creator A5000191861 @default.
• W4361010483 creator A5001602300 @default.
• W4361010483 creator A5003340740 @default.
• W4361010483 creator A5017710428 @default.
• W4361010483 creator A5033126501 @default.
• W4361010483 creator A5062239855 @default.
• W4361010483 creator A5080921373 @default.
• W4361010483 creator A5087167067 @default.
• W4361010483 date "2023-03-27" @default.
• W4361010483 modified "2023-10-11" @default.
• W4361010483 title "TANGO: Development of Consumer Information Leaflets to Support TAperiNG of Opioids in Older Adults with Low Back Pain and Hip and Knee Osteoarthritis" @default.
• W4361010483 cites W1507711477 @default.
• W4361010483 cites W1928905073 @default.
• W4361010483 cites W1965598713 @default.
• W4361010483 cites W1967390364 @default.
• W4361010483 cites W1985816353 @default.
• W4361010483 cites W1994544012 @default.
• W4361010483 cites W1997810742 @default.
• W4361010483 cites W2019181030 @default.
• W4361010483 cites W2049678371 @default.
• W4361010483 cites W2060302340 @default.
• W4361010483 cites W2069516629 @default.
• W4361010483 cites W2085842968 @default.
• W4361010483 cites W2097876737 @default.
• W4361010483 cites W2126787676 @default.
• W4361010483 cites W2140238746 @default.
• W4361010483 cites W2161736885 @default.
• W4361010483 cites W2195139277 @default.
• W4361010483 cites W2417720564 @default.
• W4361010483 cites W2519105412 @default.
• W4361010483 cites W2767526272 @default.
• W4361010483 cites W2769461077 @default.
• W4361010483 cites W2775122127 @default.
• W4361010483 cites W2791379829 @default.
• W4361010483 cites W2806855542 @default.
• W4361010483 cites W2888786751 @default.
• W4361010483 cites W2891540702 @default.
• W4361010483 cites W2911115912 @default.
• W4361010483 cites W2941496369 @default.
• W4361010483 cites W2996217938 @default.
• W4361010483 cites W3008630140 @default.
• W4361010483 cites W3008704036 @default.
• W4361010483 cites W3136165013 @default.
• W4361010483 cites W3161243729 @default.
• W4361010483 cites W4206260310 @default.
• W4361010483 cites W4221012474 @default.
• W4361010483 cites W4288074285 @default.
• W4361010483 doi "https://doi.org/10.1007/s40266-023-01011-x" @default.
• W4361010483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36972011" @default.
• W4361010483 hasPublicationYear "2023" @default.
• W4361010483 type Work @default.
• W4361010483 citedByCount "0" @default.
• W4361010483 crossrefType "journal-article" @default.
• W4361010483 hasAuthorship W4361010483A5000191861 @default.
• W4361010483 hasAuthorship W4361010483A5001602300 @default.
• W4361010483 hasAuthorship W4361010483A5003340740 @default.
• W4361010483 hasAuthorship W4361010483A5017710428 @default.
• W4361010483 hasAuthorship W4361010483A5033126501 @default.
• W4361010483 hasAuthorship W4361010483A5062239855 @default.
• W4361010483 hasAuthorship W4361010483A5080921373 @default.
• W4361010483 hasAuthorship W4361010483A5087167067 @default.
• W4361010483 hasBestOaLocation W43610104831 @default.
• W4361010483 hasConcept C107993555 @default.
• W4361010483 hasConcept C109359841 @default.
• W4361010483 hasConcept C144024400 @default.
• W4361010483 hasConcept C159110408 @default.
• W4361010483 hasConcept C1862650 @default.
• W4361010483 hasConcept C2426938 @default.
• W4361010483 hasConcept C2777929519 @default.
• W4361010483 hasConcept C2908647359 @default.
• W4361010483 hasConcept C512399662 @default.
• W4361010483 hasConcept C71924100 @default.
• W4361010483 hasConcept C99454951 @default.
• W4361010483 hasConceptScore W4361010483C107993555 @default.
• W4361010483 hasConceptScore W4361010483C109359841 @default.
• W4361010483 hasConceptScore W4361010483C144024400 @default.
• W4361010483 hasConceptScore W4361010483C159110408 @default.
• W4361010483 hasConceptScore W4361010483C1862650 @default.
• W4361010483 hasConceptScore W4361010483C2426938 @default.
• W4361010483 hasConceptScore W4361010483C2777929519 @default.
• W4361010483 hasConceptScore W4361010483C2908647359 @default.
• W4361010483 hasConceptScore W4361010483C512399662 @default.
• W4361010483 hasConceptScore W4361010483C71924100 @default.
• W4361010483 hasConceptScore W4361010483C99454951 @default.
• W4361010483 hasFunder F4320320966 @default.
• W4361010483 hasIssue "4" @default.
• W4361010483 hasLocation W43610104831 @default.
• W4361010483 hasLocation W43610104832 @default.
• W4361010483 hasLocation W43610104833 @default.
• W4361010483 hasOpenAccess W4361010483 @default.
• W4361010483 hasPrimaryLocation W43610104831 @default.
• W4361010483 hasRelatedWork W1542936630 @default.
• W4361010483 hasRelatedWork W1984922927 @default.
• W4361010483 hasRelatedWork W2017035162 @default.
• W4361010483 hasRelatedWork W2068588134 @default.
• W4361010483 hasRelatedWork W2072136885 @default.

• next